Skip to main content

Published locations for Farletuzumab may benefit patients with ovarian cancer and low CA-125 level

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Farletuzumab may benefit patients with ovarian cancer and low CA-125 level

User login

  • Reset your password
  • /content/farletuzumab-may-benefit-patients-ovarian-cancer-and-low-ca-125-level
  • /obgynnews/article/107454/gynecologic-cancer/farletuzumab-may-benefit-patients-ovarian-cancer-and-low
  • /oncologypractice/article/107454/gynecologic-cancer/farletuzumab-may-benefit-patients-ovarian-cancer
  • /obgyn/article/107454/gynecologic-cancer/farletuzumab-may-benefit-patients-ovarian-cancer-and-low-ca
  • /hematology-oncology/article/107454/gynecologic-cancer/farletuzumab-may-benefit-patients-ovarian